<DOC>
	<DOC>NCT00800332</DOC>
	<brief_summary>The purpose of the study is to test whether vaccinations with CYT003-QbG10 can improve allergy symptoms in patients with house dust mite allergy. The active treatment will be compared against placebo.</brief_summary>
	<brief_title>Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>Perennial allergic rhinoconjunctivitis due to clinically relevant allergy towards house dust mite allergens Further criteria as defined in the study protocol Clinically manifested seasonal allergy/ies which is/are expected to interfere with the patient's study treatment schedule and/or assessments Clinically relevant perennial allergy/ies other than house dust mites allergy Contraindication to any study test or procedure Further criteria as defined in the study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Rhinoconjunctivitis due to house dust mite allergy</keyword>
</DOC>